XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance at Dec. 31, 2021 $ 1,849,541 $ 7,175 $ 119,690 $ (359,425) $ 2,070,005 $ 12,096
Beginning balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 115,607       115,333 274
Other comprehensive income/(loss):            
Translation gain/(loss) 706     (185)   891
Defined benefit plan adjustment, net of tax 191     191    
Derivative financial instruments, net of tax 2,550     2,550    
Other comprehensive income/ (loss) 3,447     2,556   891
Dividends (44,124)       (44,124)  
Issuance of stock awards 377   377      
Issuance of stock awards (in shares)   182        
Shares repurchased (3,410)   (3,410)      
Shares repurchased (in shares)   (60)        
Share-based compensation 10,689   10,689      
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Ending balance at Apr. 03, 2022 1,918,931 $ 7,175 120,266 (356,869) 2,141,214 7,145
Ending balance (in shares) at Apr. 03, 2022   97,492        
Beginning balance at Dec. 31, 2022 $ 2,072,797 [1] $ 7,175 140,539 (430,083) 2,348,183 6,983
Beginning balance (in shares) at Dec. 31, 2022 97,645 97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 148,264       148,319 (55)
Other comprehensive income/(loss):            
Translation gain/(loss) 31,808     31,569   239
Defined benefit plan adjustment, net of tax 916     916    
Derivative financial instruments, net of tax 2,514     2,514    
Other comprehensive income/ (loss) 35,238     34,999   239
Dividends (48,203)       (48,203)  
Issuance of stock awards 472   472      
Issuance of stock awards (in shares)   485        
Shares repurchased (10,576)   (10,576)      
Shares repurchased (in shares)   (175)        
Share-based compensation 7,573   7,573      
Ending balance at Apr. 02, 2023 $ 2,205,565 $ 7,175 $ 138,008 $ (395,084) $ 2,448,299 $ 7,167
Ending balance (in shares) at Apr. 02, 2023 97,955 97,955        
[1] The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (the “United States” or “U.S.”).